We have shown that WCDD301 agonizes the EphA4 receptor and suppresses glucagon hypersecretion from cells (Figure 1F and Figure 2, AC) accompanied by increased F-actin polymerization (Figure 3, A, B, E, and F, and Figure 4, DH)
The effect on gastric emptying is primarily observed with the short-acting GLP-1 RAs, since significant tachyphylaxis for this effect develops after few days treatment with the long-acting GLP-1 RAs
Evaluating Biometric Trend Drivers: How to reflect medical breakthroughs and other drivers in forward-looking assumptions explores the practicalities of maintaining an up-to-date view of emerging drivers such as AOMs and provides one framework for incorporating insured impacts into insured improvement bases
Are my portions appropriate
If you're taking insulin or sulfonylureas, discuss glucose monitoring and potential dose adjustments